258 related articles for article (PubMed ID: 939694)
1. Tumor-specific immune responsiveness of the tumor-bearing host.
Burk MW; Yu S; McKhann CF
Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
[TBL] [Abstract][Full Text] [Related]
2. Refractoriness of lymph-node cells from tumour-bearing animals.
Burk MW; Yu S; Ristow SS; McKhann CF
Int J Cancer; 1975 Jan; 15(1):99-108. PubMed ID: 47843
[TBL] [Abstract][Full Text] [Related]
3. Soluble suppressor factor from the spleens of tumor-bearing mice.
Subramanian C; Yu S; McKhann CF
Cancer Res; 1978 Jul; 38(7):1996-2002. PubMed ID: 657137
[TBL] [Abstract][Full Text] [Related]
4. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
Krueger JG; Segal RA; Moyer RC
Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of thymus- and bone marrow-derived lymphocytes by tumor cells in culture.
Burk MW; Yu S; Burk KR; McKhann CF
Cancer Res; 1977 Feb; 37(2):603-9. PubMed ID: 318923
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
7. In vitro stimulation and inhibition of tumor cell growth mediated by different lymphoid cell populations.
Norbury KC
Cancer Res; 1977 May; 37(5):1408-15. PubMed ID: 66982
[TBL] [Abstract][Full Text] [Related]
8. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
9. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
Whitney RB; Levy JG
J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
[TBL] [Abstract][Full Text] [Related]
10. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
[TBL] [Abstract][Full Text] [Related]
11. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
12. K-cell cytotoxic activity in the spleen and lymph nodes of tumour-bearing mice.
Calder EA; Irvine WJ; Ghaffer A
Clin Exp Immunol; 1975 Feb; 19(2):393-7. PubMed ID: 1212806
[TBL] [Abstract][Full Text] [Related]
13. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.
Elgert KD; Farrar WL
J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939
[TBL] [Abstract][Full Text] [Related]
14. Changes in the host lymphocyte subsets during chemical carcinogenesis.
Brodt P; Lala PK
Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
[TBL] [Abstract][Full Text] [Related]
15. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
16. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
Lespinats G; Poupon MF
Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
[TBL] [Abstract][Full Text] [Related]
17. Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors.
Boyer PJ; Fahey JL
Cancer Res; 1976 Apr; 36(4):1492-8. PubMed ID: 1083290
[TBL] [Abstract][Full Text] [Related]
18. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
Tsuchiya Y; Igarashi M; Suzuki R; Kumagai K
J Immunol; 1988 Jul; 141(2):699-708. PubMed ID: 2968407
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclophosphamide on mice bearing methylcholanthrene-induced fibrosarcomas.
Yu S; Lannin DR; Tsui-Collins AL; McKhann CF
Cancer Res; 1980 Aug; 40(8 Pt 1):2756-61. PubMed ID: 7388826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
